Posted in | News | Business | Energy | Minerals

Arch Coal Acquires 25% of DKRW Advanced Fuels

Arch Coal has announced that it has acquired a 25% equity interest in DKRW Advanced Fuels, LLC. In exchange, Arch has agreed to extend its existing option agreement with DKRW Advanced Fuels, to work with DKRW Advanced Fuels to secure coal reserves for two additional coal-to-liquids projects outside of the Carbon Basin, and to invest $25 million in the company.

DKRW Advanced Fuels is a subsidiary of Houston-based DKRW Energy LLC and the principal developer of the Medicine Bow Fuel and Power coal-to-liquids project in the Carbon Basin of southern Wyoming. DKRW Advanced Fuels and its subsidiaries hold various proprietary coal conversion technology licenses and represent all of DKRW Energy LLC's coal conversion technology and development efforts within the group of DKRW Energy companies.

The Medicine Bow project is being planned as a mine-mouth coal-to-liquids facility that will use coal from Arch's Carbon Basin reserves in southern Wyoming as a feedstock. The project already has licenses in place from leading technology providers, as well as a site with nearby access to a liquids pipeline network that supplies a large and under-served refined products market. In addition, DKRW Advanced Fuels has signed a letter of intent with a regional oil and gas producer that plans to use carbon dioxide generated by the facility for enhanced oil recovery.

"We believe that our strategic partnership with DKRW Advanced Fuels positions Arch to play a significant role in the emerging coal-to-liquids industry," said Steven F. Leer, Arch Coal's chairman and chief executive officer. "DKRW Advanced Fuels is widely recognized as a leader in the coal conversion field, and it has made excellent progress in assembling the core components of a successful facility in southern Wyoming. We look forward to working with DKRW to move this project forward in the months ahead."

"Arch Coal is an industry leader in the United States coal market," said Robert C. Kelly, co-managing partner of DKRW Advanced Fuels. "Arch complements our development efforts with both coal resources and strategic thinking on coal-to-liquids. They are an excellent partner for us."

As part of the transaction, Arch and DKRW Advanced Fuels completed an extension of the existing option agreement on approximately 180 million tons of Carbon Basin coal reserves relating to the Medicine Bow coal-to-liquids project, and entered into a new agreement whereby Arch and DKRW Advanced Fuels will explore potential reserves and project opportunities of similar size to Medicine Bow in two other coal basins.

"We believe coal conversion technologies hold tremendous potential for serving America's future energy needs," Leer said. "By converting its vast and highly economic domestic coal reserves into transportation fuels and synthetic natural gas, the United States can reduce its reliance on foreign sources of energy. At the same time, coal conversion facilities that employ gasification - such as the proposed Medicine Bow plant - have exceptionally low emissions and are capable of producing an extraordinarily clean-burning product slate."

Coal conversion technologies are generally viewed as economic when crude oil is trading at prices above $35-$40 per barrel and natural gas is trading at prices above $5 per million Btus. Light sweet crude oil for October delivery most recently traded at approximately $72 per barrel on the New York Mercantile Exchange. Natural gas for October delivery most recently traded at approximately $7 per million Btus.

http://www.archcoal.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.